Objective To distinguish satisfaction with pain relief using remifentanil patient-controlled analgesia (RPCA) compared with epidural analgesia (EA) in low-risk labouring women.
Introduction
Although epidural analgesia (EA) is the most effective method of pain relief during labour, it is invasive: EA increases the risk of assisted delivery and has an increased risk of maternal fever, maternal hypotension and urinary retention. [1] [2] [3] Remifentanil-a synthetic opioid-has a fast onset of action, a short half-life and is metabolised and redistributed quickly by the fetus. 4, 5 Intravenous remifentanil patient-controlled analgesia (RPCA) offers an alternative to EA, but is associated with desaturation and respiratory depression. 4 Involvement in decision-making and having a choice in labour analgesia are important aspects of childbirth satisfaction. [6] [7] [8] Previous trials found comparable satisfaction with pain relief by RPCA and by EA, whereas they showed that EA is superior to RPCA with regard to pain scores. [9] [10] [11] [12] [13] [14] To allow women to make informed choices concerning pain relief, larger trials are needed. 15 Recently, we published the RAVEL study that compared RPCA and EA for satisfaction with pain relief among women with a medium to high obstetric risk. This trial found comparable results for all women in the trial whether or not they requested pain relief, whereas satisfaction scores for pain relief in women who received analgesia were better after EA. 16 To our knowledge, the strategies with RPCA and EA have never been compared in a group of only low-risk labouring women initially under the care of primary-care midwives. The aim of our study was to test the hypothesis that RPCA provides equivalent satisfaction with pain relief when compared with EA, using a visual analogue scale (VAS), in women with a low obstetric risk.
Methods
We performed an open label randomised controlled equivalence trial in 18 midwifery practices in the Netherlands, positioned within the Dutch Obstetric Consortium for women's health research. The protocol was approved by the ethics committee of the University Medical Centre Leiden and the boards of the six participating hospitals.
In the Netherlands, healthy pregnant women start antenatal care in primary, midwifery-led, care. Women are considered low risk if their medical and obstetric history is uneventful and they have an uncomplicated pregnancy. Women beyond 32 weeks of gestation under the care of primary-care midwives were eligible. Women younger than 18 years, women with a contra-indication for epidural analgesia or a hypersensitivity to opioid and women in whom labour had already started were not eligible.
Women were informed about the study by their midwife and after written informed consent was obtained, they were randomly allocated to a strategy with RPCA or EA in a 1 : 1 ratio, in case they should request pain relief during labour. Randomisation-always before the onset of labour -was performed using a web-based randomisation program stratified for midwifery practice and parity. Both the woman and the midwife knew the randomisation allocation in case a request for pain relief should occur during labour. Not all women received analgesia, as analgesia during labour was given only when it was requested by the women. If women requested pain relief during labour, or if medical complications occurred either before or during labour, women were referred from midwife-led primary care to obstetrician-led secondary care.
Women randomised to RPCA received intravenous remifentanil 30-lg boluses (solution 20 lg/ml) with a lockout time of 3 minutes and without background infusion. A doctor or a midwife and a nurse were responsible for providing and monitoring the RPCA. The RPCA was administered by the parturient herself after instruction on how to use RPCA in the most beneficial way, which is to use the bolus dose just before the anticipated contraction. It was possible to increase the bolus dosage to 40 lg in case of insufficient pain relief, or to decrease the dose to 20 lg in case of excessive side effects.
Women randomised to EA received EA with a loading dose of 25 mg (12.5 ml ropivacaine 0.2%) and continuous infusion of ropivacaine 0.1% plus sufentanil 0.5 lg/ml was administered. Continuous infusion was used at a variable rate defined by the anaesthetist and the local protocol. Additional boluses were used for inadequate levels of analgesia.
If analgesia with the randomly allocated pain method was insufficient according to the woman, a switch to the other trial arm was allowed.
Maternal satisfaction with labour pain scores and pain intensity scores were assessed hourly from the start of active labour until the second stage of labour in all participating women. Active stage of labour was defined as presence of regular, painful uterine contractions at regular intervals of 2-3 minutes with cervical dilatation.
Women were asked to rate their level of satisfaction with labour pain on a ruler with a VAS ranging from 0 to 10 cm (highly dissatisfied or satisfied regarding the pain, respectively). The question was specifically to judge a pain satisfaction score during active labour, not to be confused with satisfaction of childbirth. At the same time women were asked to rate their level of pain intensity on a scale ranging from 0 cm (no pain) to 10 cm (worst pain imaginable). If the women were using analgesia, they were asked to rate their satisfaction with pain relief instead of satisfaction with labour pain. Maternal vital parameters and fetal heart rate were continuously monitored in women receiving pain relief. When oxygen saturation dropped below 95% oxygen was given.
The primary outcome was satisfaction with pain relief during labour expressed as area under the curve (AUC), which is a summary measure that integrates serial VAS assessments of a woman's satisfaction with pain relief from the start of analgesia until the second stage of labour and over the total time period of active labour. The AUC could be calculated if at least two pain satisfaction scores were recorded. 17 Secondary outcomes were the AUC for pain intensity scores during labour; overall satisfaction with pain relief and pain intensity score assessed by the women 2 hours and 6 weeks after delivery. Other secondary outcomes were conversion to other methods of analgesia, time from request for pain relief to start of analgesia, duration of analgesia and of the second stage of labour, mode of delivery, maternal desaturation (<92%), maternal morbidity (post spinal headache, postpartum haemorrhage (≥1000 ml in the 24 hours after delivery or administration of blood products), suspected infection (defined as a temperature >38°C and/or use of antibiotics), uterine rupture, eclampsia, amniotic fluid embolism and myocardial infarction, admission to intensive care unit, Apgar scores after 5 minutes <7, postpartum maternal and neonatal admission to hospital, and diagnosis during admission.
The trial was an equivalence trial in which the null hypothesis was that the difference in satisfaction with pain relief score, scored on a 0-to 10-point VAS, between the two treatment groups was not equivalent. We assumed that a 10% difference would be clinically relevant in accordance with the RAVEL trial. 16 With 204 women we would have 80% power to reject the null hypothesis that the treatments are not equivalent and accept the alternative hypothesis that the proportions in the two groups are equivalent, using a 0.05 risk of type I error (two-sided test). We estimated that about 50% of participants would request pain relief. Therefore 408 women had to be randomised.
Before any analysis, we amended the protocol in February 2013 because we decided to change the primary outcome from a score at one time-point to the AUC, which integrates all VAS and can deal with missing values. Our sample size calculation was performed on a different outcome parameter. In the sample size calculations, we used 10% reduction on the pain satisfaction VAS scale as an equivalence margin, which is one point reduction in pain satisfaction.
Since we changed the primary outcome measure to a time-weighted measure by using the AUC, we could no longer use this equivalence margin. We therefore used an equivalence margin of 10% of the mean AUC.
Data were analysed on an intention-to-treat basis. We assessed equivalence with a two-sided 95% confidence interval around the estimate of the difference between the AUC satisfaction scores between the groups. Secondary outcomes were analysed for superiority. Continuous variables were summarised as means with standard deviations or medians with interquartile ranges if not normally distributed, and compared using the Student's t test or the non-parametric Mann-Whitney U test, respectively.
For categorical data, the treatment effect was presented as relative risk with 95% confidence intervals and the chisquare test was used to test for statistical differences. If the expected cell count was <5, we used the Fisher's exact test. Calculation of the percentages was based on the number of valid observations. Multiple imputation was used to account for missing primary outcome data. Missing AUC scores for satisfaction with pain relief and pain intensity were imputed 20 times, based on both the predictor variables (age, parity, gestational age, education level, body mass index, onset of labour, duration of analgesia, duration of second stage of labour, duration of admission hospital) and the outcome. 17, 18 Other missing values were not imputed .
Additional analyses were planned for women who did or did not receive analgesia; for nulliparous and multiparous women. Per-protocol analysis was planned for the group who received analgesia. We used SPSS version 22 (SPSS Inc., Chicago, IL, USA) for all analyses. P values <0.05 were considered to indicate statistical significance.
Results
Between November 2012 and June 2013, we randomised 418 women. We analysed the data of 409 women, of whom 203 women had been allocated to the RPCA group and 206 women to the EA group ( Figure 1 ). Nine women had an elective caesarean section planned after randomisation, and these women were excluded from the analysis. Baseline characteristics were comparable between the groups (Table 1) .
In the RPCA group 105/203 (52%) women requested pain relief, compared with 101/206 (49%) in the EA group. Of these women, 94/203 (46%) in the RPCA group actually received analgesia, compared with 76/206 (37%) women in the EA group (Table 2) .
In the RPCA group, reasons for not receiving analgesia despite request were vaginal delivery before RPCA was in place (n = 8), an emergency caesarean (n = 1) while for two women an anaesthetist was not available after a preference of the caregiver for EA. In the EA group, reasons for not receiving analgesia despite request were delivery before EA was in place (n = 22); no availability of an anaesthetist (n = 2) and a delayed result of platelets checked because of hypertension (n = 1).
In the RPCA group, 81/94 (86%) who requested pain relief received RPCA; 11 started with EA despite randomisation for RPCA and two used other opioids. In the EA group, 61/76 (80%) who requested pain relief received EA, 14 started with RPCA despite randomisation for EA and one used other opioids. In the RPCA group, 12/81 (15%) women switched to EA after the start of RPCA. In the women who converted to EA, 11/12 women were nulliparous and 9/12 women had ≤4 cm dilatation at request for pain relief. In the EA group one nulliparous woman who started RPCA at her own request switched to EA at 4 cm dilatation (Figure 1) .
The AUC for satisfaction with pain relief during active labour could be calculated-at least two scores availablefor 167/203 (82%) women of the RPCA group and for 141/206 (68%) women of the EA group. The AUC for pain intensity score during active labour could be calculated for 170/203 (84%) women of the RPCA group and for 143/206 (69%) of the women of the EA group. We performed an imputation for the endpoint for pain satisfaction in 36/203 women of the RPCA group and 65/206 of the EA group for the AUC. The observed value of the AUC for satisfaction with pain relief was comparable between the groups but equivalence could not be demonstrated statistically (difference 0.52; 95% CI À5.5 to 6.6). In the subgroup of women who received analgesia, satisfaction with pain relief was significantly lower in the RPCA group (difference À12; 95% CI À22 to À1.7). The AUC for pain intensity score was significantly higher in the RPCA group, both in the whole group and in the subgroup of women who actually received analgesia (difference 7.0; 95% CI 1.2-13; difference 12; 95% CI 2.1-22, respectively) ( Table 2 ).
The satisfaction with pain relief score judged by the women postpartum did not differ between the groups (see Table S1 ). The interval between request for pain relief and the start of analgesia was shorter in the RPCA group compared with the EA group (P = 0.001). Desaturation (<92%) was noted more often in the RPCA group 48/94, compared with the EA group 20/76 (RR 1.2; 95% CI 0.84-1.7). Temperature >38°C was registered in 9/94 women in the RPCA group (6/9 after switch to EA) and 6/76 women in the EA group (RR 1.2; 95% CI 0.5-3.3). Labour characteristics and maternal and neonatal outcomes were comparable in both groups (Table 3 ). There were no serious adverse events.
We performed a preplanned subgroup analysis for nulliparous and multiparous women, although interaction was not statistically significant (P = 0.34). In nulliparous women, we observed lower satisfaction with pain relief in women who received analgesia in the RPCA group compared with the EA group (difference À10; 95% CI À21 to 0.58). The AUC for pain intensity for nulliparous women was significantly higher in the RPCA group compared with the EA group (difference 8.7; 95% CI 1.0-16). For nulliparous women the duration between request for pain relief and start of analgesia was shorter in the RPCA group compared with the EA group (P = 0.005).
Among multiparous women the AUC for satisfaction with pain relief observed in the trial was higher in the RPCA group compared with the EA group although this was not significant (difference 4.7; 95% CI À0.20 to 9.7) (see Tables S2, S3 , S4). The per protocol analysis showed similar results to those for the intention-to-treat analysis (see Table S5 ).
Discussion

Main findings
The results of this study show that we cannot demonstrate that satisfaction with pain relief during labour with RPCA is equivalent to EA in low-risk labouring women. Among women who actually received analgesia scores for satisfaction with pain relief, they were significantly lower in the RPCA group compared to the EA group.
Strengths and limitations
We studied two methods of analgesia in a large sample of low-risk women. The main strength of this study is that pain satisfaction scores were measured over the whole period of active labour and expressed as AUC unlike most previous studies in which satisfaction was measured 1 hour or a maximum of 3 hours after start analgesia.
So far, there is no evidence that measuring scores throughout labour results in a different outcome to measuring an overall score at the end of labour or weeks after it. Our study provides an opportunity to compare the results of measuring satisfaction with pain relief at different moments. Also, we used satisfaction with pain relief as primary outcome, which is most relevant.
Our study also has weaknesses. We did not collect data regarding smoking or other recreational drugs. Another weakness are the missing data for the primary outcome. Missing data could be explained by the fact that hourly scoring for women in labour was a challenge, and not part of routine care. The groups with complete and incomplete data were comparable on baseline characteristics. We decided to use the AUC for the primary outcome, as this is a time-weighted measure and therefore a good overall measurement of satisfaction with pain relief and pain intensity scores. The AUC for pain scores integrates quantity and severity of pain in one outcome measure. Consequently, women with the same value of the AUC might have had different underlying pain sensations. For example, 1 hour of grade 10 unbearable pain gives the same total overall score as 3 hours of grade three to four mild pain. However, this pain will most probably be perceived differently. Also, the AUC scores are weighted the same when calculating, but this may or may not be the case. Different satisfaction scores at different points have not been examined in our study. We opted to use imputation to correct for the missing values, assuming that scores for satisfaction with pain relief were missing at random. In the intention-to-treat analysis we used multiple imputation to adjust for the missing scores. The AUCs after imputation for satisfaction with pain relief and pain intensity were comparable with the AUC without imputation, confirming that our results are a realistic reproduction of the whole group.
Pain relief was administered over a longer period of time in the epidural group compared to the RPCA group. This longer duration influences the AUC with a higher total satisfaction over a longer period of time. However, as the AUC per hour as well as the mean satisfaction score on specific time-points was significantly worse in the RPCA group, we believe that the superiority of EA was not due to this time effect.
There was a noncompliance of 12% in the RPCA group versus 18% in the EA group. Both preference for and prior belief in either RPCA or EA of doctors and women may have influenced the strategy of pain relief used because it was not possible to blind the study. Indeed, some doctors advised women to have EA instead of RPCA. It might have happened that women participated in our study to have the possibility of RPCA during labour because RPCA was only available in the context of our study. Our randomised design, however, makes the baseline profile of the two groups of women likely to be similar. Differences in pain perception are therefore due to the actual effectiveness of the treatments, as well as the knowledge of women of to which group they were allocated. The fact that women knew that they were allocated to the RPCA group or the EA group might have influenced their psychological behaviour. For example, if women had a preference for the trial arm they were not allocated to, they would probably have tried harder to cope with labour pain without any form of labour analgesia. The pain experienced in labour is effected by psychological factors. 3 The high rate of women (48% RPCA group; 51% EA group) included in our study who did not request pain relief during labour was due to the trial design. We randomised women antenatally to mimic true clinical scenarios, in which women know which analgesia they would receive if requested. We wanted to evaluate a strategy of EA versus a strategy of RPCA that included not only the effectiveness of the treatments, but also evaluated the decision for analgesia and the effect of it.
The results might not be generalisable to a population where everyone requests pain relief, as the women who actually requested pain relief could be a selection. Our strategy results in a primary outcome influenced by 'satisfaction with labour pain' for women without pain relief and 'satisfaction with subsequent pain relief' for women receiving analgesia. Both terms are a measure of the acceptability of labour pain but at the same time they may not be interchangeable. Besides, the influence of women who did request, but did not receive, pain relief is also present in both groups. Our study mimics the reality. Not receiving analgesia despite a request for it is part of daily practice in obstetrics in the Netherlands.
The distribution of scores, both pain satisfaction scores and pain intensity scores, was narrow. The only differences in the mean scores between the groups were the scores during analgesia, for both pain satisfaction score and pain intensity score. This is comparable with the AUC outcomes. In the single case that there was only one score registered, for example due to a fast delivery, this score was taken as the mean. The difference in AUC between nulliparous women and multiparous women is most likely the result of the longer interval for delivery for nulliparous compared with multiparous women.
Interpretation
The outcome of our study is comparable to our previous RAVEL study. 16 In both studies, satisfaction with pain relief during the total period of labour was comparable between the RPCA group and the EA group. Both studies showed significantly lower satisfaction with pain relief in the RPCA group after the start of analgesia and significantly higher pain intensity scores in the RPCA group during active labour.
The longer interval between the request for pain relief and the start of analgesia in the RPCA group of our study compared with the RPCA group of our previous RAVEL study could be explained by referral from midwife-led primary care to obstetrician-led secondary care in the case of a request for pain relief.
In contrast to our study, Volmanen et al. 10 and Douma et al. 11 measured comparable satisfaction with pain between RPCA and EA. These studies probably did not find a difference either because of a smaller sample size or because pain intensity scores were assessed a maximum of 3 hours after the start of analgesia whereas pain intensity scores usually increase 2 hours after the start of RPCA.
11
Comparable to previous authors, we did not find differences in satisfaction with pain relief when asked in retrospect. 9, [11] [12] [13] Our trial confirms previous studies in the superiority of EA over RPCA for pain intensity measured during active labour. 3 As it is generally accepted that analgesia during labour should be available, alternatives are needed when EA is not, immediately, available, contraindicated or not preferred by the woman.
The preference of some women for RPCA, although randomised for EA, indicates that women consider other favourable factors more important than the effectiveness of pain relief.
The percentage of women who requested pain relief was comparable between both groups. More women in the RPCA group received analgesia, because RPCA could be started without an anaesthetist. Besides, RPCA was provided even at the end of the first stage of labour whereas EA was not provided to women late in the first stage of labour, which is a common policy in some countries, including the Netherlands. Hence, women in need of pain relief might choose RPCA when the expected time to delivery is short.
Although there was no significant interaction between parity and pain relief method we observed a higher satisfaction with pain relief in the RPCA subgroup of multiparous women compared with the EA group, which could be clinically relevant. This could be explained by the shorter use of analgesia in this group which is favourable for RPCA. In previous studies pain intensity scores during RPCA increased over time whereas pain scores during EA were sustained over time. 9, 11 Besides, most of the multiparous women who asked for pain relief but did not receive pain relief belonged to the EA group (10/60), compared with 3/ 65 in the RPCA subgroup. In our opinion, especially for multiparous women RPCA is an attractive option for analgesia with acceptable satisfaction scores. These women will usually take advantage of fast delivery combined with rapid availability and short use of pain relief.
The incidence of desaturation in our study confirms the well-known risk of respiratory complications during RPCA. [3] [4] [5] 16, 19 Measuring of the respiratory rate was, at least during our study, not a standard procedure in all the hospitals. 19 Despite the frequently monitored desaturation we did not observe respiratory depression or serious complications in either group. RPCA should only be used with careful monitoring for respiratory complications and in the attendance of trained healthcare providers.
The cross-over from RPCA to EA was comparable to previous studies. 16, 19 In clinical practice the dilatation at request of pain relief is usually taken into account when decision for a strategy of analgesia is made, possibly leading to lower cross-over rates. Nulliparous women who were dilated ≤4 cm are at risk for insufficient analgesia with RPCA. Caregivers should take this into account when counselling for analgesia during labour.
The result of our study facilitates shared decision-making about analgesia during labour. Pregnant women should be fully informed about the options for analgesia including the effects, limitations and risks of these options. RPCA should particularly be discussed in multiparous women.
Conclusion
When comparing a strategy for RPCA with EA in women at low risk for complications, equivalence could not be demonstrated with respect to satisfaction with pain relief assessed during the total time of labour. However, once applied, satisfaction with pain relief was higher in women who received EA. Since RPCA is in many settings more readily available than EA, it can be an alternative for pain relief during labour.
Disclosure of interests
Full disclosure of interests available to view online as supporting information.
Contribution to authorship
SL is the guarantor. Study concept and design were by SL, KOR, CV and BWM; statistical analysis was by SL, KOR and CV; drafting the concept was by SL, KOR, CV and BWM; and all authors contributed to the critical revision of the manuscript for important intellectual content. The guarantor affirms that the manuscript is an honest, accurate and transparent account of the study being reported, that no important aspects of the study have been omitted and that any discrepancies from the study as planned haven been explained. 
Details of ethics approval
Funding
For this study we did not receive funding or supplies (such as financial supply or supply of drugs).
Supporting Information
Additional Supporting Information may be found in the online version of this article: Table S1 . Secondary outcome: Mean (SD) satisfaction with pain relief and pain intensity score. Table S2 . Subgroup analysis nulliparous women. Table S3 . Subgroup analysis multiparous women. Table S4 . Labour characteristics nulliparous and multiparous women. Table S5 . Per protocol analysis. &
